… the risk of stroke in patients with atrial fibrillation, followed by … stroke prevention to all who
are not at low risk of stroke. … phase of atrial fibrillation rather than wait for stroke to be the first …

… Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary
of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by …

… an overview of antithrombotic therapy for stroke prevention in AF. We discuss risk factors
for stroke, risk stratification, and new developments for stroke prevention in patients with AF. …

… an important opportunity for stroke prevention. The … stroke, the identification of AF patients
with particularly high and low rates of stroke, and the efficacies and risks of stroke prevention …

… ), patients with acute ischaemic stroke and patients with an … stroke prevention strategies,
including left atrial appendage occlusion, in patients with atrial fibrillation at high risk of stroke …

… 23, 1999, of stroke prevention in atrial fibrillation that evaluated either warfarin or aspirin
therapy alone or in combination. Search terms were atrial fibrillation, stroke, warfarin, aspirin, …

… We conclude that stroke prevention remains a dominant part of the management of patients
… with new-onset AF, given that the default should be stroke prevention unless the patient is …

… Stroke prevention is the cornerstone of the management of atrial fibrillation (AF), and effective
stroke prevention … worldwide, the landscape of stroke prevention has changed markedly in …

… Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.
… Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. …

… major results and clinical implications of the SPAF trials, offering unique perspectives on the
optimal use of antithrombotic therapies for stroke prevention in patients with atrial fibrillation. …